Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy (2012)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- DOI: 10.1007/s10633-012-9322-5
- Subjects: ANTICORPOS MONOCLONAIS; ELETRORRETINOGRAFIA; DIABETES MELLITUS; RETINA (PATOLOGIA)
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2012
- Source:
- Título: Documenta Ophthalmologica
- ISSN: 0012-4486
- Volume/Número/Paginação/Ano: v. 124, n. 3, p. 225-236, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MESSIAS, André Márcio Vieira et al. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Documenta Ophthalmologica, v. 124, n. 3, p. 225-236, 2012Tradução . . Disponível em: https://doi.org/10.1007/s10633-012-9322-5. Acesso em: 30 dez. 2025. -
APA
Messias, A. M. V., Ramos Filho, J. A., Messias, K., Almeida, F. P. P. de, Costa, R. A., Scott, I. U., et al. (2012). Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Documenta Ophthalmologica, 124( 3), 225-236. doi:10.1007/s10633-012-9322-5 -
NLM
Messias AMV, Ramos Filho JA, Messias K, Almeida FPP de, Costa RA, Scott IU, Gekeler F, Jorge R. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy [Internet]. Documenta Ophthalmologica. 2012 ; 124( 3): 225-236.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1007/s10633-012-9322-5 -
Vancouver
Messias AMV, Ramos Filho JA, Messias K, Almeida FPP de, Costa RA, Scott IU, Gekeler F, Jorge R. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy [Internet]. Documenta Ophthalmologica. 2012 ; 124( 3): 225-236.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1007/s10633-012-9322-5 - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
Informações sobre o DOI: 10.1007/s10633-012-9322-5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
